Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
2,441
+124
+5% +$49.4K 0.23% 83
2026
Q2
$839K Buy
2,317
+161
+7% +$55.1K 0.19% 103
2026
Q1
$759K Buy
+2,156
New +$769K 0.19% 100
2024
Q4
– Sell
-1,684
Closed -$543K – 224
2024
Q3
$543K Buy
+1,684
New +$551K 0.18% 99
2023
Q4
– Sell
-761
Closed -$204K – 198
2023
Q3
$204K Buy
+761
New +$190K 0.09% 186

Other funds holding AMGN

TrueWealth Advisors's AMGN Position: Q3 2026 in Review

TrueWealth Advisors increased its Amgen (AMGN) stake by 5.4% in Q3 2026, buying an estimated $49.4K and bringing the position to 2,441 shares worth $1.03M. The position accounts for 0.23% of the portfolio, ranked #83.

TrueWealth Advisors first reported a position in AMGN in Q3 2023 and has held it in 5 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • TrueWealth Advisors held 2,441 shares of Amgen worth $1.03M as of Q3 2026.
  • TrueWealth Advisors bought 124 Amgen shares in Q3 2026, an estimated $49.4K.
  • Amgen made up 0.23% of TrueWealth Advisors's portfolio in Q3 2026, its #83 holding.
  • TrueWealth Advisors first reported a position in Amgen in Q3 2023 and has held it in 5 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on TrueWealth Advisors's 13F filing for Q3 2026, filed 9 Oct 2026.